⌘K
Loading ticker…
Mustang Bio, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Mustang Bio, Inc. (MBIO) has a 3-month relative strength percentile of 32 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 12.0%, relative volume 0.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
32 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
MBIO is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -0.1% / -32.5%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
MBIO appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $19K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $19K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MBIO Jan avg: 6.36% median: 2.52% win: 50% σ: 50.43% n: 4 2022-04-12 → 2026-05-29 | MBIO Feb avg: -18.53% median: -12.54% win: 25% σ: 25.34% n: 4 2022-04-12 → 2026-05-29 | MBIO Mar avg: -30.43% median: -30.63% win: 0% σ: 6.34% n: 4 2022-04-12 → 2026-05-29 | MBIO Apr avg: -25.48% median: -17.32% win: 20% σ: 29.77% n: 5 2022-04-12 → 2026-05-29 | MBIO May avg: 5.82% median: -9.57% win: 40% σ: 29.31% n: 5 2022-04-12 → 2026-05-29 | MBIO Jun avg: 23.97% median: -6.07% win: 25% σ: 74.79% n: 4 2022-04-12 → 2026-05-29 (current) | MBIO Jul avg: 3.43% median: -8.56% win: 25% σ: 39.60% n: 4 2022-04-12 → 2026-05-29 | MBIO Aug avg: -12.86% median: -8.57% win: 25% σ: 19.47% n: 4 2022-04-12 → 2026-05-29 | MBIO Sep avg: -18.27% median: -19.53% win: 25% σ: 14.74% n: 4 2022-04-12 → 2026-05-29 | MBIO Oct avg: 2.25% median: 5.39% win: 50% σ: 18.53% n: 4 2022-04-12 → 2026-05-29 | MBIO Nov avg: -12.62% median: -9.48% win: 0% σ: 11.43% n: 4 2022-04-12 → 2026-05-29 | MBIO Dec avg: -17.44% median: -16.54% win: 0% σ: 10.81% n: 4 2022-04-12 → 2026-05-29 |